Results of Phase II trial to assess the efficacy and safety of idelalisib
Results of trial of vadastuximab talirine plus hypomethylating agents in AML
What is the role of inotuzumab ozogamicin in ALL
Comparing ibrutinib efficacy and toxicity levels by age for patients with CLL/SLL
How can genetic analysis be used to determine chronic lymphocytic leukemia (CLL) treatment?